Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis

ClinicalTrials.gov ID: NCT02289417

Public ClinicalTrials.gov record NCT02289417. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 9:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the clinical efficacy, safety and tolerability of apremilast (30 mg twice daily \[BID\] and 40 mg BID), compared with placebo, in participants with active Ulcerative Colitis (UC).

Study identification

NCT ID
NCT02289417
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
170 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 7, 2015
Primary completion
Sep 24, 2017
Completion
Jun 2, 2019
Last update posted
May 6, 2020

2015 – 2019

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
Digestive Health Specialists of The Southeast Dothan Alabama 36305
Southern California Research Institute Medical Group, Inc. Los Angeles California 90045
Connecticut Clinical Research Foundation Bristol Connecticut 06010
Consultants for Clinical Research of South Florida Boynton Beach Florida 33426
Avail Clinical Research, LLC DeLand Florida 32720
Precision Clinical Research, LLC Lauderdale Lakes Florida 33319
Pharmax Research Clinic, Inc. Miami Florida 33126
Gastroenterology Group of Naples Naples Florida 34102
Advanced Medical Research Center Port Orange Florida 32127
University of Chicago Medical Center Chicago Illinois 60637
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
University of Louisville Louisville Kentucky 40202
UMass Medical Center Worcester Massachusetts 01655
Clinical Research Institute of Michigan, LLC Chesterfield Michigan 48047
Center for Digestive Health Research Troy Michigan 48098
Gastrointestinal Associates PA Flowood Mississippi 39232
NYU Langone Long Island Clinical Research Associates Great Neck New York 11021
Consultants for Clinical Research Cincinnati Ohio 45219
Quality Medical Research Nashville Tennessee 37211
Digestive Research Center/ Gastroenterology Consultants of San Antonio Live Oak Texas 78233
Digestive Health Specialist of Tyler Pasadena Texas 77505
San Antonio Gastroenterology San Antonio Texas 78229
University of Utah Salt Lake City Utah 84132
Harborview Medical Center Seattle Washington 98104
University of Washington Medical Center Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 74 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02289417, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2020 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02289417 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →